Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Large Volume Parenteral (LVP) Market Size, Value And Growth Trends Through 2030

The global market for large volume parenteral (LVP) solutions has experienced robust expansion lately. Projections indicate this sector will expand from $13.53 billion in 2025 to $14.76 billion in 2026, reflecting a compound annual growth rate of 9.1%. Key factors contributing to this growth during the preceding period include an upward trend in hospital admissions, increased reliance on intravenous fluid therapies, a rise in the number of surgical interventions, enhancements in critical care facilities, and advancements in managing infectious diseases.

The global market for large volume parenteral (LVP) solutions is poised for significant expansion, projected to reach $21.37 billion by the year 2030, registering a compound annual growth rate of 9.7% through the forecasted period. This upward trajectory is primarily fueled by an increasing elderly demographic, a higher incidence of long-term health conditions, a greater need for nutritional support via parenteral routes, the development of healthcare facilities in developing economies, and an increased provision of emergency and trauma medical services. Key developments shaping this market in the coming years include a surge in preference for environmentally friendly and PVC-free LVP containers, a greater availability of pre-prepared and mixed infusion products, an intensified emphasis on maintaining sterile conditions and preventing contamination, a broader application of LVPs in critical care settings and emergency medicine, and an overall increase in the volume of intravenous therapies administered within hospitals.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

Large Volume Parenteral (LVP) Market Expansion Supported By Key Demand Factors

The escalating incidence of long-term illnesses is anticipated to be a significant catalyst for the expansion of the large-volume parenteral market in the future. Chronic diseases, characterized by conditions persisting for three months or more and potentially progressing over time, are largely attributed to factors such as tobacco consumption, exposure to secondhand smoke, and inadequate dietary habits. Patients suffering from these ailments necessitate a balanced intake of vital nutrients essential for maintaining bodily strength, and parenteral administration proves advantageous by ensuring direct absorption of pharmaceutical dosages into the bloodstream, bypassing the digestive tract. Illustratively, the World Health Organization reported in September 2023 that non-communicable diseases, or chronic conditions, were responsible for 41 million deaths annually worldwide, accounting for 74% of all fatalities. Consequently, the increased prevalence of chronic diseases serves as a primary driver for the growth observed in the large-volume parenteral market.

Augmenting healthcare spending is projected to significantly boost the large-volume parenteral market in the coming period. This increase in financial investment towards healthcare encompasses a broader allocation of resources for medical services, research, and public health initiatives. Enhanced financial commitment often correlates with the development and fortification of healthcare infrastructure, including the establishment of new medical centers and facilities, thereby increasing the capacity for service delivery and consequently stimulating the demand for large-volume parenteral products. As an example, the American Medical Association indicated in April 2025 that US healthcare spending experienced a substantial rise of 7.5% in 2023, reaching $4.9 trillion or $14,570 per individual, a notable uptick from the 4.6% growth noted in the preceding year. Hence, the upward trend in healthcare expenditure is a key factor propelling the expansion of the large-volume parenteral market.

Large Volume Parenteral (LVP) Market Segment Landscape And Growth Potential

The large volume parenteral (lvp) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Large Volume Parenteral (LVP) Market Growth Trends Influencing Competitive Dynamics

Global leaders in the large volume parenteral (LVP) market are prioritizing the creation of smart infusion device advancements, specifically intelligent large-volume infusion pumps, to address the growing need for enhanced safety, automation, and connectivity in intravenous therapy. This trend is fueled by the expansion of hospital-based infusion services, the rise of remote patient monitoring, and the industry-wide drive for standardized, error-minimizing medication administration. An intelligent large-volume infusion pump distinguishes itself from conventional devices by incorporating dose-error reduction software, smart drug library capabilities, and advanced alarm management, going beyond the manual programming and basic automation of older models. These sophisticated pumps are engineered to deliver substantial IV fluid volumes while actively preventing medication errors, easing healthcare professionals’ workloads, and seamlessly integrating with hospital information technology infrastructures. As a prime example, Baxter International Inc. secured U.S. FDA approval in April 2024 for its Novum IQ Large-Volume Infusion Pump, featuring the integrated Dose IQ smart-dose software. This innovative pump facilitates rapid fluid delivery, including extensive volume infusions, and boasts safety mechanisms like drug library integration to mitigate dosing inaccuracies, alongside the capability to link with hospital electronic health records and intelligent monitoring systems, ultimately empowering clinicians to enhance infusion precision, diminish the likelihood of dosage errors, and optimize workflows for high-volume IV therapies, ensuring safer and more efficient patient care.

Large Volume Parenteral (LVP) Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare

Access The Complete Large Volume Parenteral (LVP) Market Report:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Large Volume Parenteral (LVP) Market Regional Outlook: Where Are The Largest Opportunities Located?

North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model